Talking to Your Doctor
Start the conversation with the Doctor Discussion Guide
This Guide is meant to help start the conversation with your doctor about your individual walking needs living with multiple sclerosis (MS).
Since being diagnosed with MS, have you noticed any changes in your walking? For example, have you started to avoid activities that require walking? Has crossing the street in time to make the light become more difficult? Do you find it harder to walk in crowded places like airports or the mall? These are important matters to discuss with your doctor.
The Self-Assessment in this Guide will help you evaluate your current walking ability. It is based on the 12-Item Multiple Sclerosis Walking Scale (or MSWS-12)—a scale that can be used by people with MS to rate the impact of MS on their walking ability.
You can personalize this downloadable Guide to help start the conversation with your healthcare team.
Select which questions you’d like to appear in your Guide, then save it as a PDF, print it out, or email it to yourself.
Or, if you are in a hurry...
PDF | 187kb | 8 pages
About PDF Files
PDF stands for "Portable Document Format." PDF files require Adobe Acrobat Reader, which can be downloaded free from the Adobe website at www.adobe.com.
Important notice: Acorda respects your right to have personal and medical information kept confidential. Acorda
cannot access this information.
THE SELF-ASSESSMENT IN THE DISCUSSION GUIDE IS INTENDED FOR INFORMATIONAL PURPOSES ONLY. IT IS NOT A SUBSTITUTE FOR PROFESSIONAL MEDICAL ADVICE, DIAGNOSIS OR TREATMENT.
AMPYRA® (dalfampridine) is indicated as a treatment to improve walking in patients with MS. AMPYRA improved walking in significantly more people with MS than placebo (sugar pill) in two clinical trials (34.8% vs. 8.3% and 42.9% vs. 9.3%). This was demonstrated by an increase in walking speed. In the clinical studies, people who walked faster, regardless of treatment, also reported improvements in their walking-related activities.† This was shown using the 12-Item Multiple Sclerosis Walking Scale (or MSWS-12).
Not everyone responds to AMPYRA. Individual results may vary.
†A drug/placebo difference was not established for this outcome measure.